VIDEO: Antibody-drug conjugates, oral taxanes show potential in breast cancer
Click Here to Manage Email Alerts
In this video, Patrick Borgen, MD, chair of the department of surgery at Maimonides Medical Center, discussed the effectiveness of antibody-drug conjugates in the breast cancer setting and the promise of oral taxanes at the 38th Annual Miami Breast Cancer Conference.
“[Antibody-drug conjugates] are incredibly effective agents and, frankly, many of us believe are the future of oncology,” Borgan said.
He also talked about a new class of taxanes that are oral, which are gentler to administer and may yield less side effects like neurotoxicity, according to Borgan.
“Taxanes have been cornerstones of breast cancer treatment…so to have the option of oral taxane is really exciting for our patients.”
Collapse
Read more about
Click Here to Manage Email Alerts